Heart failure affects an estimated 40 to 60 million individuals globally. Find out how Sartorius and the biotech company Repairon are #InThisTogether for a cure 🤝💛 Shortly after birth, our heart muscle cells lose their ability to divide. This means that damage such as a heart attack leads to an irreversible loss of these cells. As a result, the heart's ability to pump effectively decreases, which can lead to heart failure. For over two decades, the team at Repairon has been researching to develop the so-called heart patch. This new heart tissue is artificially grown from stem cells in the lab and then sewn onto special membranes compatible with the human body. ❤️🩹 ➡️ Discover how Sartorius supports Repairon in the production of stem cells for heart patches on the Sartorius Blog: https://ow.ly/gPXZ50Svinq #SimplifyingProgress #PartOfTheSolution #HeartFailure #HeartPatch #Production
Sartorius
Biotechnologieforschung
Göttingen, Lower Saxony 174.877 Follower:innen
A Trusted Partner of Life Sciences Research and Biopharmaceutical Manufacturing | #SimplifyingProgress
Info
Sartorius is a leading international partner of life sciences research and biopharmaceutical manufacturing. We help our customers #SimplifyProgress from drug discovery to manufacturing so that more people can have access to better medicine. With this, we are #PartOfTheSolution in the fight against diseases worldwide. With innovative laboratory instruments and consumables, the our Lab Products & Services division focuses on laboratories performing research and quality control at pharmaceutical and biopharmaceutical companies as well as academic research institutes. The Bioprocess Solutions division, with its broad product portfolio focusing on single-use solutions, helps customers manufacture biotech medications, vaccines, and cell and gene therapies safely, rapidly, and economically. Based in Göttingen, Germany, Sartorius also has a strong global reach with around 60 production and sales sites worldwide. We regularly expand our portfolio through the acquisition of complementary technologies. In 2023, Sartorius generated sales revenue of around 3.4 billion euros. Currently, around 14,600 employees from around 110 nations are working for customers around the globe. Join our team, partner or collaborate with us.
- Website
-
http://www.sartorius.com
Externer Link zu Sartorius
- Branche
- Biotechnologieforschung
- Größe
- 10.001+ Beschäftigte
- Hauptsitz
- Göttingen, Lower Saxony
- Art
- Kapitalgesellschaft (AG, GmbH, UG etc.)
- Gegründet
- 1870
Orte
Beschäftigte von Sartorius
-
Robert Brotherus
Lead Software Engineer at Sartorius-Biohit Liquid Handling Oy
-
Torsten G. Mueller
Chief Information Officer / Managing Director at Sartorius
-
Johan Hultman
Manager @ Sartorius | IIoT and Data Analysis
-
Michael Youngquist
Innovator in Life Sciences Instrumentation
Updates
-
Recapping #PrideMonth!🌈 As June, dedicated to celebrating the LGBTQ+ community, comes to an end, we would like to spotlight the activities that employee resource groups at Sartorius organized and hosted. 🌟 Highlights of this year’s Pride Month: - Participation in the Long Island Pride Parade - Pride Celebration and Employee Appreciation Party - Virtual Panel Discussion with participants from Sartorius’ sites around the world All events had one goal: to focus on the LGBTQ+ community, raise awareness of their challenges, and promote a culture of diversity, equity, belonging, and inclusion within the company. Read more about the events on the Sartorius blog: https://sar.to/njtvo #LGBT #PrideMonth #Diversity #DEIB
-
-
Have you ever heard of the mosquito-borne chikungunya virus? According to the WHO, more than two million cases of chikungunya infections, which cause flu-like symptoms and severe joint pain, have been reported since 2005. No vaccine was available against the virus – until Sartorius’ customer Valneva had their vaccine approved by the FDA in late 2023. Learn more on the Sartorius blog about how we are part of the solution and how recombinant albumin from Albumedix now a part of Sartorius, stabilizes the vaccine during storage and transport: https://sar.to/voytu #PartOfTheSolution #SimplifyingProgress #Bioprocessing #BetterHealth
Part of the Solution: How Recombinant Albumin Supports the World’s First Chikungunya Vaccine
-
🔬 Did you know that mitochondria, the powerhouse of our cells, are inherited from our mothers? These tiny organelles are not just crucial for our health but also play a significant role in cancer. Cancer cells rely on mitochondria for energy, especially in harsh environments where nutrients are scarce. Mitochondria help these cells by producing ATP, a more efficient energy source than glycolysis. This process is key for tumor growth and survival. Understanding the intricate dance between cancer cells and mitochondria is vital. It sheds light on how tumors resist drugs and continue to thrive. Learn more about the world of cellular energy and cancer resilience - download the infographic: https://ow.ly/7N9c50Soprv Follow Incucyte® - Live-Cell Analysis Systems to find out more about observing and quantifying complex biological changes in real-time. #SimplifyingProgress #CancerResearch #Mitochondria #CellBiology #Cancer #livecellimaging
-
Is time of the essence? The clocks are ticking louder for scientists and engineers researching new treatments for cancer, genetic disorders, and the pandemics of tomorrow. Moving quickly from discovering to delivering biological therapeutics can make or break its success. Sartorius’ single-use technologies are a speed boost, cutting production time and costs, while enhancing flexibility. This empowers research teams around the world to simplify and accelerate progress in life science and bioprocessing. We’re in this together. Expedite your drug to market through rapid deployment of single-use solutions. Discover our scalable single-use technologies at www.sartorius.com #SimplifyingProgress #LifeSciences #bioprocessing #InThisTogether
-
🔬 Bringing our cutting-edge solutions closer to you: Sartorius announces the opening of a new Application Center in #Aubagne, France. Located in Southern Europe, our new Application Center is tailored to enhance your accessibility and convenience. Our facility spans 350 square meters of state-of-the-art lab space, where you can engage with experts and experience all our end-to-end process solutions covering the entire value chain for biopharmaceutical research and manufacturing. In particular, gain deep insights into single-use bags, tubing, connectors, and assemblies of integrated single-use systems for the production, storage, and transportation of biopharmaceuticals. Let's shape the future of biopharma together! Connect with us to explore how our solutions can enhance your production capabilities. Whether you prefer an in-person walkthrough or a virtual demo, our team is ready to dive into your unique challenges and accelerate your journey from concept to production. 🧑🤝 ➡️ Book your visit now: https://sar.to/ac-aubagne 💡 Learn more about Sartorius Application Centers: https://lnkd.in/eR6QQUig #SimplifyingProgress #ApplicationCenter #Biopharma #Bioanalytics #DrugDiscovery #LifeScience
-
-
The wait is over: Introducing Arium®️ Mini Extend Optimize your lab water purification with ultimate flexibility on minimum space and improve your lab experience with an innovative dispensing unit. ✅ Easily Removable Dispensing Unit - Magnetic mount for ergonomic handling - Splash-free filling into diverse containers ✅ Control at Your Fingertips - Manual and volume-controlled water dispensing - Dispense and modify the last volume with ease - All dispensing functions accessible via color touch display and dispensing unit ✅ Reliably High Water Quality - Consistency in your experiments Learn more: https://ow.ly/HfLZ50SiKob #Sartorius #Innovation #Arium #SimplifyingProgress #Laboratory #LabEssentials #WaterPurification #WaterSystems
-
Striving towards making a positive impact on UN sustainability goal number 3 – health and well-being? Scientists worldwide are tirelessly working to discover new solutions against cancer, inheritable diseases, and future pandemics. Sartorius supports them with cutting-edge technologies that help translate scientific discoveries into effective therapies more quickly. So that patients get the treatments they need. In doing so, together, we are making an impact to “health and well-being”. We're in this together. Our innovations enable you to provide more people with access to better healthcare. Let's join forces and improve social sustainability and more at www.sartorius.com #SimplifyingProgress #LifeSciences #bioprocessing #InThisTogether
-
The Ann Arbor Center of Excellence for Bioanalytics is new to Sartorius – but Sartorius is not new to Ann Arbor. Did you know that Sartorius left its first footprints in this vibrant university town more than a century ago? While the roots and experience of our Ann Arbor-based bioanalytics and microcarrier technology business can be traced back 40 years, Florenz Sartorius' lab instruments already enabled researchers and pharmacists to significantly speed up their experiments at the beginning of the last century. 🔬⚖🥼 Today, our bioanalytical and cell culture solutions help customers advance life science research and accelerate drug development. Both now and then, our innovative tools have been helping researchers make scientific discoveries. 🧬💡 ➡️ Swipe through the slide deck and discover more about Sartorius' history in Ann Arbor. #SimplifyingProgress #InThisTogether #AnnArbor #Michigan #BioTechnology #Bioanalytics #DrugDiscovery #LifeScience
-
Construction completed in Ann Arbor! 🏗️✔️ Two years after breaking ground in the Tech Loop at Research Park, Sartorius today celebrates the opening of its new Center of Excellence for Bioanalytics in Ann Arbor, #Michigan, USA. The 130,000-square-foot facility houses a modern manufacturing and services area, biology labs, a warehouse, office and training spaces, as well as a Customer Interaction Center (CIC). It was built with a focus on sustainability. "Sartorius is a leading provider of highly automated bioanalytical solutions that are used in the discovery and development of innovative biopharmaceutical drugs. With our new flagship site in Ann Arbor, we are bringing together our core competencies and dedicated experts under one roof, further strengthening our ability to address key customer needs in this highly innovative and relevant field," said Dr. Alexandra Gatzemeyer, Head of the Lab Products & Services division and member of the Executive Board of Sartorius. Read media release: https://lnkd.in/en7uenKX 🤝 Ann Arbor SPARK Michigan Economic Development Corporation Innovation Partnerships #SimplifyingProgress #Bioanalytics #BioTechnology #DrugDiscovery #LifeScience
-
Verbundene Seiten
Ähnliche Seiten
Jobs durchsuchen
Finanzierung
Sartorius
Insgesamt 1 Finanzierungsrunde
Weitere Informationen auf Crunchbase
Letzte Runde
Fremdkapital nach Börsengang
Externer Crunchbase-Link für die letzte Finanzierungsrunde
3.209.472.652,00 $